Lung cancer gene test without surgery shows promise
NCT ID NCT01487603
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a small sample taken from lung cancer patients during a routine biopsy (called EBUS-TBNA) can be used to analyze genes that predict how well treatments like chemotherapy or surgery might work. Researchers plan to enroll 400 adults with confirmed or suspected lung cancer. The goal is to see if this less invasive method can replace surgery for getting the genetic information needed to personalize treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors choose more effective treatments for lung cancer patients without needing surgery.
What could go wrong
This is an early feasibility study, not a treatment trial. It may not lead to immediate changes in care, and the gene analysis might not always be accurate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
University Health Network
RECRUITINGToronto, Ontario, Canada
Contact Phone: •••-•••-••••